CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.02B
Enterprise Value 31.05B
Trailing P/E N/A
Forward P/E 1-122.58
PEG Ratio (5 yr expected) 1-0.49
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-5.32

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Dec 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-95.66%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-106.38M
EBITDA -197.32M
Net Income Avi to Common (ttm)-209.34M
Diluted EPS (ttm)-3.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)72.36M
Total Cash Per Share (mrq)1.04
Total Debt (mrq)103.09M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.54
Book Value Per Share (mrq)-0.56

Cash Flow Statement

Operating Cash Flow (ttm)-159.27M
Levered Free Cash Flow (ttm)-81.32M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.93
52-Week Change 323.87%
S&P500 52-Week Change 38.63%
52 Week High 320.66
52 Week Low 38.32
50-Day Moving Average 314.41
200-Day Moving Average 312.63

Share Statistics

Avg Vol (3 month) 3809.05k
Avg Vol (10 day) 3808.29k
Shares Outstanding 569.34M
Float 59.23M
% Held by Insiders 13.54%
% Held by Institutions 197.45%
Shares Short (Mar 29, 2019) 48.23M
Short Ratio (Mar 29, 2019) 411.52
Short % of Float (Mar 29, 2019) 422.62%
Short % of Shares Outstanding (Mar 29, 2019) 411.88%
Shares Short (prior month Feb 28, 2019) 49.2M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A